Short and Optimal Duration of Dual Antiplatelet Therapy Study
Status:
Completed
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate safety of reduction of thienopyridine treatment
period to 3 months after implantation of Cobalt-Chromium everolimus-eluting Stents.